Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer
Autor: | Ji Young Kim, Hyunsook An, Nahyun Lee, Eunhye Oh, Jae Hong Seo, Youngkwan Cho, Tae Min Cho, Daeil Sung |
---|---|
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Cancer Research Time Factors Receptor ErbB-2 Acetaldehyde Dehydrogenase Inhibitors Mice Nude Apoptosis Breast Neoplasms Pharmacology Biology Aldehyde Dehydrogenase 1 Family 03 medical and health sciences 0302 clinical medicine Cancer stem cell Antineoplastic Combined Chemotherapy Protocols Disulfiram medicine Animals Humans Phosphorylation skin and connective tissue diseases Protein kinase B Mice Inbred BALB C Dose-Response Relationship Drug Akt/PKB signaling pathway Retinal Dehydrogenase Cancer Aldehyde Dehydrogenase medicine.disease Xenograft Model Antitumor Assays Tumor Burden ALDH1A1 Phenotype 030104 developmental biology Oncology 030220 oncology & carcinogenesis Cancer cell MCF-7 Cells Neoplastic Stem Cells biology.protein Female Signal transduction Proto-Oncogene Proteins c-akt Copper Cyclin-Dependent Kinase Inhibitor p27 Signal Transduction |
Zdroj: | Cancer Letters. 379:39-48 |
ISSN: | 0304-3835 |
Popis: | HER2-positive breast tumors are known to harbor cancer stem-like cell populations and are associated with an aggressive tumor phenotype and poor clinical outcomes. Disulfiram (DSF), an anti-alcoholism drug, is known to elicit cytotoxicity in many cancer cell types in the presence of copper (Cu). The objective of the present study was to investigate the mechanism of action responsible for the induction of apoptosis by DSF/Cu and its effect on cancer stem cell properties in HER2-positive breast cancers in vitro and in vivo. DSF/Cu treatment induced apoptosis, associated with a marked decrease in HER2, truncated p95HER2, phospho-HER2, HER3, phospho-HER3 and phospho-Akt levels, and p27 nuclear accumulation. This was accompanied by the eradication of cancer stem-like populations, concomitant with the suppression of aldehyde dehydrogenase 1 (ALDH1) activity and mammosphere formation. DSF administration resulted in a significant reduction in tumor growth and an enhancement of apoptosis, as well as HER2 intracellular domain (ICD) and ALDH1A1 downregulation. Our results demonstrate that DSF/Cu induces apoptosis and eliminates cancer stem-like cells via the suppression of HER2/Akt signaling, suggesting that DSF may be potentially effective for the treatment of HER2-positive cancers. |
Databáze: | OpenAIRE |
Externí odkaz: |